[1]
Groll AH, Walsh TJ. Uncommon opportunistic fungi new nosocomial threats. Clin Microbiol Infect 2001; 7: 8-24.
[2]
Giraldo P, Von Nowakowski A, Gomes FA, et al. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 2000; 95: 413-6.
[5]
Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10: 14-9.
[7]
Schmidt M, Dzogbeta S, Boyer MP. Inhibition of Candida albicans by Fluvastatin Is dependent on pH. Biochem Res Int 2009; 2009: 151424.
[8]
Nash JD, Burgess DS, Talbert RL. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. Indian J Med Microbiol 2002; 51: 105-9.
[9]
Chin NX, Weitzman I, Della-Latta P. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 1997; 41: 850-2.
[10]
Chaffin WL. Candida albicans cell wall proteins. Microbiol Mol Biol Rev 2008; 72: 495-544.
[11]
Podust LM, Poulos TL, Waterman MR. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001; 98: 3068-73.
[12]
Hess B, Kutzner C, Van Der Spoel D, et al. GROMACS 4. Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2014; 4: 435-47.
[13]
Kant K, Lal UR, Kumar A, Ghosh M. A merged molecular docking, ADME-T and dynamics approaches towards the genus of Arisaema as herpes simplex virus type 1 and type 2 inhibitors. Comput Bioland Chem 2019; 78: 217-26.
[14]
Essmann U, Perera L, Berkowitz M, et al. A smooth particle mesh Ewald method. J Phys Chem Biophys 1995; 103: 8577-93.
[15]
SchuÈttelkopf AW,Van Aalten DM. PRODRG a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D. Acta Crystallogr 2004; 60: 1355-63.
[16]
Grant BJ, Rodrigues AP, ElSawy KM, et al. Bio3d: anR package for the comparative analysis of protein structures. BMC Bioinformatics 2006; 22: 2695-6.
[17]
Amadei A, Linssen A, Berendsen HJ. Essential dynamics of proteins. Proteins: Struct, Funct, Bioinf. Proteins 1993; 17: 412-25.
[18]
García AE. Large-amplitude nonlinear motions in proteins. Phys Rev Lett 1992; 68: 2696-700.
[19]
Balsera MA, Wriggers W, Oono Y, et al. Principal component analysis and long time protein dynamics. J Phys Chem B 1996; 100: 2567-72.
[21]
Gupta M, Sharma R, Kumar A. Comparative potential of Simvastatin, Rosuvastatin and Fluvastatin against bacterial infection: an in silico and in vitro study. Orient Pharm Exp Med 2019; 1-17.
[22]
Wu WS, Chen CC, Chuang YC, et al. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect 2013; 46: 89-95.
[23]
Kumar A, Sharma N. Comparative efficacy of piperine and curcumin in deltamethrin induced splenic apoptosis and altered immune functions. Pestic Biochem Physiol 2015; 119: 16-27.
[24]
Jacob KS, Ganguly S, Kumar P, et al. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy. J Biomol Struct Dyn 2017; 35: 1446-63.
[25]
Yang AS, Honig B. An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments1. Biochem Mol Biol J 2000; 301: 691-711.
[26]
Rost B. Twilight zone of protein sequence alignments. Korean J Chem Eng 1999; 12: 85-94.
[27]
Meyer T, Ferrer-Costa C, Pérez A, et al. Essential dynamics: a tool for efficient trajectory compression and management. J Chem Theory Comput 2006; 2: 251-8.
[28]
Li W, Shen J, Liu G, et al. Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations. Proteins 2011; 79: 271-81.
[29]
Shen J, Li W, Liu G, et al. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors. J Phys Chem B 2009; 113: 10436-44.
[30]
Nygaard R, Zou Y, Dror RO, et al. The dynamic process of β2-adrenergic receptor activation. Cell 2013; 152: 532-42.
[31]
Kruse AC, Hu J, Pan AC, et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nat 2012; 482: 552-9.
[32]
Lindorff-Larsen K, Piana S, Dror RO, et al. How fast-folding proteins fold. Sci 2011; 334: 517-20.
[33]
Piana S, Lindorff-Larsen K, Shaw DE. Atomic-level description of ubiquitin folding. Proc Natl Acad Sci USA 2013; 110: 5915-20.
